Literature DB >> 22257677

ERα, microRNAs, and the epithelial-mesenchymal transition in breast cancer.

Irene K Guttilla1, Brian D Adams, Bruce A White.   

Abstract

The most common form of breast cancer, luminal A, is estrogen receptor α (ERα)-positive and epithelial, but nevertheless can metastasize. The process of epithelial-mesenchymal transition (EMT) is probably the first step in the metastasis of epithelial cancers. We discuss the characteristics of EMT, including factors that induce EMT, and the relationship of EMT to cancer stem cells (CSCs). Estrogen/ERα signaling maintains an epithelial phenotype and suppresses EMT. An overview of microRNAs in breast cancer is presented, including how microRNA biogenesis is altered in cancer and regulated by ERα. We also discuss the role of the miR-200 family in opposing EMT. Finally, we discuss specific microRNAs that target ERα and regulate EMT in breast cancer, and the role of these microRNAs in breast cancer progression.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22257677     DOI: 10.1016/j.tem.2011.12.001

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  51 in total

1.  MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer.

Authors:  Lei Huo; Yan Wang; Yun Gong; Savitri Krishnamurthy; Jing Wang; Lixia Diao; Chang-Gong Liu; Xiuping Liu; Feng Lin; William F Symmans; Wei Wei; Xinna Zhang; Li Sun; Ricardo H Alvarez; Naoto T Ueno; Tamer M Fouad; Kenichi Harano; Bisrat G Debeb; Yun Wu; James Reuben; Massimo Cristofanilli; Zhuang Zuo
Journal:  Mod Pathol       Date:  2016-02-26       Impact factor: 7.842

2.  Epigenetic inactivation of miR-203 as a key step in neural crest epithelial-to-mesenchymal transition.

Authors:  Estefanía Sánchez-Vásquez; Marianne E Bronner; Pablo H Strobl-Mazzulla
Journal:  Development       Date:  2019-04-11       Impact factor: 6.868

Review 3.  Connecting sex differences, estrogen signaling, and microRNAs in cardiac fibrosis.

Authors:  Lejla Medzikovic; Laila Aryan; Mansoureh Eghbali
Journal:  J Mol Med (Berl)       Date:  2019-08-26       Impact factor: 4.599

4.  Differential effects of estrogen-dependent transactivation vs. transrepression by the estrogen receptor on invasiveness of HER2 overexpressing breast cancer cells.

Authors:  Mugdha Patki; Marcela d'alincourt Salazar; Robert Trumbly; Manohar Ratnam
Journal:  Biochem Biophys Res Commun       Date:  2015-01-09       Impact factor: 3.575

5.  Regulation of the microRNA 200b (miRNA-200b) by transcriptional regulators PEA3 and ELK-1 protein affects expression of Pin1 protein to control anoikis.

Authors:  Xusen Zhang; Bailin Zhang; Jidong Gao; Xiang Wang; Zhihua Liu
Journal:  J Biol Chem       Date:  2013-09-26       Impact factor: 5.157

Review 6.  Noncoding RNAs in breast cancer.

Authors:  Pang-Kuo Lo; Benjamin Wolfson; Xipeng Zhou; Nadire Duru; Ramkishore Gernapudi; Qun Zhou
Journal:  Brief Funct Genomics       Date:  2015-12-18       Impact factor: 4.241

Review 7.  Regulation of epithelial-mesenchymal transition in endometrial cancer: connecting PI3K, estrogen signaling, and microRNAs.

Authors:  C N Kent; I K Guttilla Reed
Journal:  Clin Transl Oncol       Date:  2016-02-08       Impact factor: 3.405

8.  [Medium-chain acyl-CoA dehydrogenase enhances invasion and metastasis ability of breast cancer cells].

Authors:  Yinjue Yu; Linfeng Zhao; Rong Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-06-30

9.  The RUNX2 Transcription Factor Negatively Regulates SIRT6 Expression to Alter Glucose Metabolism in Breast Cancer Cells.

Authors:  Moran Choe; Jessica L Brusgard; Saranya Chumsri; Lekhana Bhandary; Xianfeng Frank Zhao; Song Lu; Olga G Goloubeva; Brian M Polster; Gary M Fiskum; Geoffrey D Girnun; Myoung Sook Kim; Antonino Passaniti
Journal:  J Cell Biochem       Date:  2015-10       Impact factor: 4.429

10.  Progesterone receptor A promotes invasiveness and metastasis of luminal breast cancer by suppressing regulation of critical microRNAs by estrogen.

Authors:  Thomas McFall; Brooke McKnight; Rayna Rosati; Seongho Kim; Yanfang Huang; Nerissa Viola-Villegas; Manohar Ratnam
Journal:  J Biol Chem       Date:  2017-11-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.